Low-Grade Lymphoma: Clinical and Prognostic Studies in a Series of 143 Patients from a Single Institution

References

• Non-Hodgkin's lymphoma pathologic classification project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112–2135
   PubMed Web of Science ®Google Scholar
• Lennert K., Feller A.C. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification), 2nd ed. Springer Verlag, Berlin 1990
   Google Scholar
• Montserrat E., Lopez-Guillermo A., Rozman C. B-cell low-grade malignant lymphomas. Haematology trends 1993, K. Lechner, H. Gadner-Stuttgart. Schattauer, New York 1993; 56–79
   Google Scholar
• Gallagher C.J., Gregory W.M., Jones A.E., et al. Follicular lymphoma: Prognostic factors for response and survival. J. Clin. Oncol. 1986; 4: 1470–1480
   PubMed Web of Science ®Google Scholar
• Leonard R. C. F., Hayward R.L., Prescott R.J., Wang J.X. The identification of discrete prognostic groups in low-grade non-Hodgkin's lymphoma. Ann. Oncol. 1991; 2: 655–667
   PubMed Web of Science ®Google Scholar
• Litam P., Swan S., Cabanillas F., et al. Prognostic value of serum Beta-2 microglobulin in low-grade lymphoma. Ann. Intern. Med. 1991; 114: 855–860
   PubMed Web of Science ®Google Scholar
• Romaguera J.E., McLaughlin P., North L., et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. J. Clin. Oncol. 1991; 9: 762–769
   PubMed Web of Science ®Google Scholar
• Soubeyran P., Eghibali H., Bonichon F., Trojani M., Ri-Chaud P., Hoerni B. Low-grade follicular lymphoma: analysis of prognosis in a series of 281 patients. Eur. J. Cancer Clin. Oncol. 1991; 27: 1606–1613
   Google Scholar
• Bastion Y., Berger F., Bryon P.A., Feldman P., Ffrench M., Coiffier B. Follicular lymphomas: assessment of prognostic factors in 127 patients followed for 10 years. Ann. Oncol. 1991; 2(Suppl. 2)123–129
   PubMed Web of Science ®Google Scholar
• Cameron D.A., Leonard Jian-Hua R. C. F., Mao and Prescott R.J. Identification of prognostic groups in follicular lymphoma. Leukemia and Lymphoma 1993; 10: 89–99
   PubMed Web of Science ®Google Scholar
• Coiffier B. How should prognostic factors influence therapy in follicular lymphomas?. Ann. Oncol. 1991; 2: 619–620
   PubMed Web of Science ®Google Scholar
• Freedman A.S., Ritz J., Neuberg D., et al. Autologous bone marrow transplantation in 69 patients with a history of low-grade B-cell non-Hodgkin's lymphoma. Blood 1991; 77: 2524–2529
   PubMed Web of Science ®Google Scholar
• Rohatiner A. Z. S., Lister T.A. Myeloablative therapy for follicular lymphoma. Hematol./Oncol. Clin. N. Am. 1991; 5: 1003–1012
   PubMed Web of Science ®Google Scholar
• Kaplan G.L., Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc 1958; 53: 457–481
   Web of Science ®Google Scholar
• Peto R., Pike M.C. Conservatism of the approximation (O - E)2/E in the log-rank test for survival data or tumour incidence data. Biometrics 1973; 29: 759–784
   Google Scholar
• Mantel N., Byar D.P. Evaluation of response time data involving transient status: An illustration using heart transplant data. J. Am. Stat. Assoc 1974; 69: 81–86
   Web of Science ®Google Scholar
• Cox D.R. Regression model and life tables. J. R. Stat. Assoc 1972; 34: 187–220
   Web of Science ®Google Scholar
• Dixon W.J., Brown M.B., Engelman L., et al. BMDP Statistical Software. University of California Press, Berkeley 1986; 719–743
   Google Scholar
• Cabanillas F., Smith T., Bodey G.P., Gutterman J.U., Freireich E.J. Nodular malignant lymphomas. Factors affecting complete response rate and survival. Cancer 1979; 44: 1983–1989
   PubMed Web of Science ®Google Scholar
• Anderson T., De Vita V.T., Jr, Simon S.M., et al. Malignant lymphoma. II Prognostic factors and response to treatment of 473 patients at the National Cancer Institute. Cancer 1982; 50: 2708–2721
   PubMed Web of Science ®Google Scholar
• Ezdinli E.Z., Costello W.G., Kucuk O., Berard C.W. Effect of the degree of nodularity on the survival of patients with nodular lymphomas. J. Clin. Oncol. 1987; 5: 413–418
   PubMed Web of Science ®Google Scholar
• McLaughlin P., Fuller L.M., Velasquez W.S., Butler J.J., Hagemeister F.B., Sullivan-Halley J.A., Dixon D.O. Stage III follicular lymphoma: durable remissions with combined chemotherapy-radiotherapy regimen. J. Clin. Oncol. 1987; 5: 867–874
   PubMed Web of Science ®Google Scholar
• Griffin N.R., Howard M.R., Quirke P., O'Brien C.J., Child J.A., Bird C.C. Prognostic indicators in centroblastic-centrocytic lymphoma. J. Clin. Pathol. 1988; 451: 866–870
   Web of Science ®Google Scholar
• De Vita V.T., Jr, Jaffe E.S., Mauch P., Longo D.L. Lymphocytic lymphomas. Cancer: Principles and Practice of Oncology, 3rd ed., V.T. De Vita, Jr, S. Hellman, S.A. Rosenberg, V.T. De Vita, Jr., E.S. Jaffe, P. Mauch, D.L. Longo. Lipincott JV, Philadelphia 1989; 1741–1798
   Google Scholar
• Lepage E., Sebban C., Gisselbrecht C., et al. Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trial. Hematol. Oncol. 1990; 8: 31–39
   PubMed Web of Science ®Google Scholar
• Macartney J.C., Camplejohn R.S., Morris R., Hollowood K., Clarke D., Timothy A. DNA flow cytometry of follicular non-Hodgkin's lymphoma. J. Clin. Pathol. 1991; 44: 215–218
   PubMed Web of Science ®Google Scholar
• Garcia-Zueco J.C., Delgado M.P., Giraldo M.P., et al. Linfomas no hodgkinianos II. Analisis de los factores pronosticos en una serie de 307 enfermos. Sangre (Bare) 1992; 37: 337–344
   PubMedGoogle Scholar
• Steward W.P., Crowther D., McWilliam L.J., et al. Maintenance chlorambucil after CVP in the management of advanced stage, low-grade histologic type non-Hodgkin's lymphoma. Cancer 1988; 61: 441–447
   PubMed Web of Science ®Google Scholar
• Weisdorf D.J., Andersen J.W., Glick J.H., Oken M.M. Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for bone marrow transplantation. J. Clin. Oncol. 1992; 10: 942–947
   PubMed Web of Science ®Google Scholar
• Longo D.L., Young R.C., Hubbard S.M., et al. Prolonged initial remission in patients with nodular mixed lymphoma. Ann. Intern. Med. 1984; 100: 651–656
   PubMed Web of Science ®Google Scholar
• Spinolo J.A., Cabanillas F., Dixon D.O., et al. Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure. Ann. Oncol. 1992; 3: 227–232
   PubMed Web of Science ®Google Scholar
• Hubbard S.M., Chabner B.A., DeVita V.T., et al. Histologic progression in non-Hodgkin's lymphoma. Blood 1982; 59: 258–264
   PubMed Web of Science ®Google Scholar